The long road of drug development for endometriosis – Pains, gains, and hopes

review OA: green CC0 ⤵ 4 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This review discusses the challenges and progress in developing drugs for endometriosis, highlighting existing limitations and future prospects for treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development Drug Development

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-06-04T00:32:22.903660+00:00
License: CC0 · commercial use OK